Y-Intercept (HK)’s Minerva Neurosciences NERV Stock Holding History

Y-Intercept (HK)’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-64,687	Closed	-$359K	–	1926
2026 Q2	$359K	Buy	+64,687	New	+$351K	0.01%	1414
2021 Q3	–	Sell	-1,266	Closed	-$23K	–	822
2021 Q2	$23K	Buy	+1,266	New	+$27.3K	0.01%	581

Other funds holding NERV

Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Y-Intercept (HK)'s NERV Position: Q3 2026 in Review

Y-Intercept (HK) sold out of Minerva Neurosciences (NERV) in Q3 2026, closing a stake of 64,687 shares — an estimated $359K sold.

Y-Intercept (HK) first reported a position in NERV in Q2 2021 and held it in 2 quarters. The position peaked at $359K in Q2 2026. 4 funds tracked by Wall St. Rank hold NERV as of Q3 2026.

Y-Intercept (HK) reported no remaining Minerva Neurosciences position as of Q3 2026 after selling out during the quarter.
Y-Intercept (HK) sold 64,687 Minerva Neurosciences shares in Q3 2026, an estimated $359K.
Y-Intercept (HK) first reported a position in Minerva Neurosciences in Q2 2021 and held it in 2 quarters.
Y-Intercept (HK)'s Minerva Neurosciences position peaked at $359K in Q2 2026.
4 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.